● Recruiting

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Condition: Atopic Dermatitis · Sponsor: Novartis Pharmaceuticals

PhasePhase 2

Planned participants224

Who can joinAll sexes, 18 Years to 100 Years

Healthy volunteersNo

About this study

This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals · 1-888-669-6682 · novartis.email@novartis.com

Novartis Pharmaceuticals · +41613241111

Always discuss trial participation with your own doctor first.

Locations (99)

Novartis Investigative Site	Birmingham, Alabama, United States	Recruiting
Novartis Investigative Site	Birmingham, Alabama, United States	Recruiting
Novartis Investigative Site	Fort Smith, Arkansas, United States	Recruiting
Novartis Investigative Site	Fountain Valley, California, United States	Recruiting
Novartis Investigative Site	Los Angeles, California, United States	Recruiting
Novartis Investigative Site	Sacramento, California, United States	Recruiting
Novartis Investigative Site	Santa Ana, California, United States	Recruiting
Novartis Investigative Site	Santa Monica, California, United States	Recruiting
Novartis Investigative Site	Washington D.C., District of Columbia, United States	Recruiting
Novartis Investigative Site	Miami, Florida, United States	Recruiting
Novartis Investigative Site	Atlanta, Georgia, United States	Recruiting
Novartis Investigative Site	Macon, Georgia, United States	Recruiting

+ 87 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06947993